Phibro Animal Health (PAHC) Shares Outstanding (2012 - 2026)
Phibro Animal Health (PAHC) posted quarterly Shares Outstanding (Entity) of $40.6 million for Q1 2026, little changed year-over-year from $40.5 million in Q1 2025, and little changed quarter-over-quarter from $40.5 million in Q4 2025.
Phibro Animal Health (PAHC) Shares Outstanding (2012 - 2026) Analysis & Trends
Phibro Animal Health's Shares Outstanding (Entity) history runs 14 years deep, the most recent figure standing at $40.6 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) changed 0.08% year-over-year to $40.6 million; the TTM figure through Mar 2026 stood at $40.6 million (changed 0.08% YoY), while the FY2025 annual figure was $40.5 million, changed 0.07% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $40.6 million, roughly flat from $40.5 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $40.6 million in Q1 2026, with the low at $40.5 million in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $40.5 million (2022), against an average of $40.5 million.
- Peak annual rise in Shares Outstanding (Entity) reached 99975.63% in 2022, while the deepest fall reached 0.0% in 2022.
- Phibro Animal Health's Shares Outstanding (Entity) stood at $40.5 million in 2022, then changed by 0.0% to $40.5 million in 2023, then changed by 0.0% to $40.5 million in 2024, then climbed by 0.08% to $40.5 million in 2025, then climbed by 0.08% to $40.6 million in 2026.
- Business Quant data shows PAHC's Shares Outstanding (Entity) at $40.6 million in Q1 2026, $40.5 million in Q4 2025, and $40.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 832.44 Mn |
| 10 | Phibro Animal Health | 1.45 Bn | 1.37 Bn | 125.68 Mn | 40.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.55 Mn |
| Dec 31, 2025 | 40.53 Mn |
| Sep 30, 2025 | 40.53 Mn |
| Jun 30, 2025 | 40.52 Mn |
| Mar 31, 2025 | 40.52 Mn |
| Dec 31, 2024 | 40.50 Mn |
| Sep 30, 2024 | 40.50 Mn |
| Jun 30, 2024 | 40.50 Mn |
| Mar 31, 2024 | 40.50 Mn |
| Dec 31, 2023 | 40.50 Mn |
| Sep 30, 2023 | 40.50 Mn |
| Jun 30, 2023 | 40.50 Mn |
| Mar 31, 2023 | 40.50 Mn |
| Dec 31, 2022 | 40.50 Mn |
| Sep 30, 2022 | 40.50 Mn |
| Jun 30, 2022 | 40.50 Mn |
| Mar 31, 2022 | 40.50 Mn |
| Dec 31, 2021 | 40.50 Mn |
| Sep 30, 2021 | 40.50 Mn |
| Jun 30, 2021 | 40,473.00 |